Gain Therapeutics Inc. (GANX)
Sector: | NA |
Super Investor Stats: | |
Ownership count: | 1 |
Ownership rank: | 686 |
% of all portfolios: | 0.001% |
| |
Total insider Buys/Sells last 6 months: |
| Transactions | Total |
Buys |
1 |
$115,770 |
Sells |
2 |
$5,057 |
Open Market Insider Buys
Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
01 Apr 2024 |
RILEY JEFFREY SCOTT |
Director |
28 Mar 2024 |
30,000 |
3.86 |
115,770 |
27 May 2022 |
RICHMAN ERIC I |
CHIEF EXECUTIVE OFFICER |
25 May 2022 |
2,482 |
2.58 |
6,404 |
23 May 2022 |
RICHMAN ERIC I |
CHIEF EXECUTIVE OFFICER |
20 May 2022 |
9,256 |
2.83 |
26,194 |
23 May 2022 |
RICHMAN ERIC I |
CHIEF EXECUTIVE OFFICER |
19 May 2022 |
4,000 |
2.71 |
10,840 |
19 May 2022 |
CALABRESE SALVATORE |
CHIEF FINANCIAL OFFICER |
19 May 2022 |
3,000 |
8100.00 |
24,300,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock